Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Size: px
Start display at page:

Download "Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University"

Transcription

1 Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

2 Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of random variability in clinical studies Describe, understand, and learn how to control the 3 main types of bias: Confounding Information bias / measurement error Selection bias Discuss the concept of generalizability of study results DCR Chapters 4 and 9 2

3 Threats to causal inference Truth in the Universe infer Truth in the Study infer Findings in the study Research Question Random and systematic error Study Plan Random and systematic error Actual Study Target Population Intended Sample Actual subjects Design Implementation Phenomena of interest Intended variables Actual measurement s EXTERNAL VALIDITY INTERNAL VALIDITY 3

4 Bias Systematic difference between the true value and the measured value How close is the measured value to the true value? Synonym for bias: lack of validity Validity on average, the measurement estimates the true measurement

5 Real example of random error! Body weight, bathroom scale True body weight 180 lbs Inconsistent scale, but set correctly at 0 lbs Moments apart: 1 st measurement: lbs 2 nd measurement: lbs 3 rd measurement: lbs 4 th measurement: lbs

6 Real example of bias! Body weight, bathroom scale True body weight 180 lbs Consistent scale, but fail to set it at 0 lbs: reads -5 lbs Moments apart: 1 st measurement: 175 lbs 2 nd measurement: 175 lbs 3 rd measurement: 175 lbs 4 th measurement: 175 lbs

7 Threats to causal inference Lack of precision Random variability - by chance We may observe an association that does not exist or may fail to observe an existing association Lack of internal validity Bias - Systematic errors Confounding Information bias / measurement error Selection bias 7

8 Threats to causal inference Incorrect assessment of the direction of causality: We believe that A B But, in reality A B Lack of external validity (generalizability): True effect in the study population But, does not apply to other populations 8

9 Precision vs. validity Meta-analysis of long-term large randomized controlled trials of statins and coronary heart disease endpoints 9

10 Streptokinase in AMI Meta-analysis Lau J, et al. N Engl J Med 1992;327:

11 Smoking and CVD mortality NHANES II Mortality Study Sample size: 9,205 Length of follow-up: 16 years Prevalence at baseline Current smokers: 32.2% Former smokers: 26.8% Never smokers: 41.0% Hazard ratio for all-cause mortality: Current vs. never smokers: 2.08 (95% CI ) Former vs. never smokers: 1.32 (95% CI ) 11

12 Smoking and CVD mortality NHANES II Mortality Study Hazard ratios for mortality in random samples of N = 500 Ex-smokers Curr. smk [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20]

13 Smoking and CVD mortality NHANES II Mortality Study Hazard ratios for mortality comparing current to never smokers N = 500 N = 1, N = 5,000 N = 9,205

14 Smoking and CVD mortality NHANES II Mortality Study Hazard ratios for mortality comparing former to never smokers N = 500 N = 1, N = 5,000 N = 9,205 14

15 Bias definition Deviation of results or inferences from the truth Any trend in the collection, analysis, interpretation, publication, or review of data that can lead to conclusions that are systematically different from the truth Last JM, ed. A dictionary of epidemiology, 4th ed. Oxford, Oxford University Press,

16 Bias classification Many different biases have been described Sackett DL. Bias in analytic research. J Chron Dis 1979;32:51-63 Delgado-Rodriguez M, Llorca J. J Epidemiol Community Health 2004;58: general types of biases: Confounding Misclassification / Information bias Selection bias 16

17 From causal effect to data 17

18 Direction of Bias (I)

19 Direction of Bias (II)

20 From causal effect to data

21 Confounders are factors that Cause the disease (or are surrogates for causal factors) AND Have a different distribution in exposed and unexposed populations (i.e., are associated with the exposure in the study sample) Both conditions need to be present to have confounding We will also need the additional condition that the confounder is not affected by the exposure

22 Confounders have to 1. Cause the disease (or be a surrogate measure of a cause) AND 2. Be associated with exposure (i.e., be distributed differently between exposed and unexposed), AND 3. Not affected by exposure (i.e., not be an intermediate variable in the causal pathway) Note: the 3 conditions are necessary for a variable to be a confounder 22

23 Concepts of confounding MI No MI Coffee No coffee Odd ratio (OR)= Smokers Nonsmokers MI No MI MI No MI Coffee No Coffee OR in smokers= OR in nonsmokers=

24 Concepts of confounding

25 Concepts of confounding

26 Concepts of confounding

27 Concepts of confounding

28 Concepts of confounding

29 Confounding 29

30 Asking about sex 30

31 Comparability of exposure groups 31

32 Sex and mortality Results 32

33 Sex and mortality Recommendations! 33

34 Causal associations Low sex frequency Death from myocardial infarction Low sex frequency Death from myocardial infarction Poor health

35 35

36 Hypotheses 36

37 Methods 37

38 Results and interpretation 38

39 Causal diagram Sexual behavior HIV infection AIDS Use of amyl nitrite 39

40 Confounders are factors that Cause the disease (or are surrogates for causal factors) AND Have a different distribution in exposed and unexposed populations (i.e., are associated with the exposure in the study sample) Both conditions need to be present to have confounding We will also need the additional condition that the confounder is not affected by the exposure

41 Amyl nitrite, HIV infection, and AIDS Sexual behavior HIV infection AIDS Use of amyl nitrite HIV infection causes AIDS HIV infection and use of amyl nitrite were associated in homosexual men 41

42 Confounders have to 1. Cause the disease (or be a surrogate measure of a cause) AND 2. Be associated with exposure (i.e., be distributed differently between exposed and unexposed), AND 3. Not affected by exposure (i.e., not be an intermediate variable in the causal pathway) Note: the 3 conditions are necessary for a variable to be a confounder 42

43 Causal diagram Physical activity, HDL cholesterol, and MI Low physical activity Low HDL cholesterol Myocardial infarction Low physical activity is a cause low HDL cholesterol Low HDL cholesterol is a cause of myocardial infarction HOWEVER, low HDL cholesterol is an intermediate variable in the causal pathway between physical activity and myocardial infarction 43

44

45 Uncontrolled confounding Unmeasured confounders Unknown confounders Known confounders that are too expensive or difficult to measure Residual confounding Confounder is measured imperfectly, and cannot be controlled completely 45

46 Results and interpretation 46

47 Confounding by indication 47

48 In practice (I) Prior knowledge on the biological and other causal relationships is needed to properly identify which variables to adjust for Do NOT apply statistical criteria to decide if the conditions for confounding are present Testing for the association of confounder with exposure and of confounder with disease Stepwise selection procedures Consider if exposed and unexposed subjects are comparable with respect to their risk of disease (except for exposure) 48

49 In practice (II) Consider which determinants of disease may be responsible for the lack of comparability Elaborate causal diagram Identify causal factors that may be different between exposed and unexposed Obtain information on potential confounders Measuring confounders with error will result in residual confounding after adjustment Use statistical techniques to adjust for potential confounders 49

50 Methods to control for confounding In the design of the study Randomization Restriction Matching primarily in case-control studies In the analysis Standardization Stratification Multivariate models Propensity scores Inverse probability weighting Sensitivity analysis 50

51 Enrollment and follow-up in HERS Grady D, et al. JAMA 2002;288:

52 52

53 53

54 54

55 Restriction Restrict eligibility into the study to one category of the confounder Advantages Convenient, inexpensive and easy to implement Adequate control of confounder Simple analysis Disadvantages Cannot evaluate effect modification May limit generalizability For continuous variables, need to group the restriction variable (possibility of residual confounding) Can only be applied to a small number of variables 55

56 Restriction to lifetime non-smokers to avoid confounding by smoking

57 57

58 From causal effect to data 58

59 Selection bias The measure of association observed in the study sample is different to the measure of association in the source population Selection into the study is affected both by the exposure (or by a cause of the exposure) AND by a cause of the outcome (in cohort studies) or by the outcome (in case-control studies) Source population Study population Exposed Disease No disease Disease No disease A B Exposed b a C D Nonexposed Nonexposed c d 59

60 (1000 ) (2000 ) Risk = = 0.01 Risk = = risk 0.01 Relative risk = = risk = 4

61 (1000 ) (2000 ) : 15 ( Hx 10, Hx 5 ) : 15 ( Hx 10, Hx 5 ) odd = odd = = 2 = 2 Odds ratio = 2 2 = 1

62 1) Fat intake? : multi-center :

63 (1000 ) (2000 ) : 15 ( Hx 10, Hx 5 ) : 15 ( Hx 1, Hx 14 ) odd = odd = = 2 = Odds ratio = = 28

64

65 (1000 ) (2000 ) : 15 ( 10, 5 ) : 15 ( 5, 10 ) odd = odd = = 2 = 0.5 Odds ratio = = 4

66

67 MacMachon B, et al. N Engl J Med 1981;304:630-3

68 MacMachon B, et al. N Engl J Med 1981;304:630-3

69

70 Selection bias in Case-Control Study

71 (%)

72

73

74 Selection bias in Case-Control Study

75 Selection bias in cohort studies Immigrative selection bias Selection into the cohort is affected both by exposure (or by a cause of exposure) and by risk of disease Emigrative selection bias Selection out of the cohort (losses to follow-up) are affected both by exposure (or by a cause of exposure) and by risk of disease 75

76 Healthy Worker Effect

77 77

78 78

79 79

80 Honolulu Heart Study Rate of CHD, stroke and total mortality in 11,136 men of Japanese ancestry eligible in ,006 men examined and 3,130 not examined (60% completed a mailed questionnaire) Baseline smoking as current, ever or never All 11,136 followed through

81 Differential smoking by participation Examined Unexamined N = 8,006 N = 3,130 Smoking: Ever 69% 72% Current 48% 53% Age-standardized %, p value < 0.01 Selection into cohort associated with smoking 81

82 82

83 Rate ratios for current smoking Examined (Study) N = 8,006 Un-Examined N = 3,130 Source N = 11,136 Total CVD Stroke

84 Samaha FF, et al. N Engl J Med 2003;348:

85 Samaha FF, et al. N Engl J Med 2003;348:

86 86

87 Selection bias due to losses of follow-up in RCT of Atkins diet Assigned diet Selection Outcome (weight loss) Age, other factors

88 Minimizing selection bias Random sampling from source population Limit losses to follow up Sensitivity analysis 88

89 From causal effect to data Phillips CV. Epidemiology 2003;14:

90 Measurement error can affect Exposure Outcome Confounders Mediators Modifying factors 90

91 Error components Measured value = True value + Error Error = Bias + Random Error Systematic component of the error Random component of the error

92 Quantification of measurement error Dichotomous variables Sensitivity, specificity Kappa statistic Categorical variables Spearman correlation coefficient Kappa statistic Continuous variables Coefficient of variation Intraclass correlation coefficient (reliability coefficient) 92

93 Differential vs. non-differential errors Non-differential measurement error Measurement error in the variable in question (e.g., the exposure) does not depend on the levels of other variables (e.g., the outcome, confounders, etc) Differential measurement error Measurement error depends on the levels of other variables (for instance, when sensitivity and specificity for measuring disease are different in exposed and unexposed participants) 93

94 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED EXPOSURE Sensitivity = 80% Specificity = 100% Observed RR = 1.71 Diseased Yes No Exposed Yes No

95 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED EXPOSURE Sensitivity = 100% Specificity = 90% Observed RR = 1.91 Diseased Yes No Exposed Yes No

96 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED EXPOSURE Sensitivity = 80% Specificity = 90% Observed RR = 1.60 Diseased Yes No Exposed Yes No

97 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure In this case, measurement error will induce a bias will be towards the null, unless The test is uninformative or misleading The true effect is null The magnitude of the bias depends on: Sensitivity and specificity The prevalence of the exposure The risk of the disease The magnitude of the true effect The measure of association used 97

98 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure 98

99 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure

100 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure

101 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring exposure

102 Non-differential measurement error Dichotomous exposure & outcome Errors in measuring disease TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED DISEASE Sensitivity = 80% Specificity = 90% Observed RR = 1.41 Diseased Yes No Exposed Yes No

103

104

105

106

107

108

109

110 Regression towards the mean When a variable is measured with random error and we select participants with observed extreme values, their true underlying values are on average closer to the population mean Measure BP and select participants with SBP > 140 mmhg Consequences Inconsistencies in diagnosis and classification Biases in evaluation of interventions Inefficiency in planning studies 110

111 Differential measurement error Dichotomous exposure & outcome Errors in measuring disease TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED DISEASE Diseased Yes No Exposed Yes No Sens in exposed = 90% Sens in unexposed = 80% Spec in exposed = 100% Spec in unexposed = 100% Observed RR =

112 Differential measurement error Dichotomous exposure & outcome Errors in measuring disease TRUE TABLE N = 2000 P(E) = 50% P(D E ) = 10% RR = 2.0 Diseased Yes No Exposed Yes No TABLE WITH MISCLASSIFIED DISEASE Diseased Yes No Exposed Yes No Sens in exposed = 100% Sens in unexposed = 100% Spec in exposed = 90% Spec in unexposed = 80% Observed RR =

113 Differential measurement error Can bias measures of association in any direction The magnitude can be substantial, even with small differences in sensitivity or specificity In cohort studies, an important concern is differential classification of disease as a function of exposure Diagnostic bias Surveillance bias Mask follow-up procedures and outcome assessment 113

114 Main points on measurement error Measurement errors are pervasive in epidemiological studies Non-differential, independent errors in exposure or outcome tend to bias associations towards the null, but there are exceptions Differential or dependent errors can bias the association in either direction If sensitivity / specificity or ICC are known from validation studies, we can correct the measures of association 114

115 Strategies for increasing accuracy of measurements Standardize measurement methods in an operations manual Train and certify observers Refine the instruments Automate instruments and procedures Calibrate equipment Make unobtrusive measurements Blind measurements Take repeated measurements

116 Generalizability (external validity) 116

117 PPV Information Sheet 117

118 Generalizability is a judgment Consider if the same biological / social mechanisms apply in the target population as in the source population Consider if the prevalence of factors that may modify the effect of the exposure are different in the target and in the source population E.g., genetic determinants Be careful 118

119 Any question?

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Understand goal of measurement and definition of accuracy Describe the threats to causal

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

INTERNAL VALIDITY, BIAS AND CONFOUNDING

INTERNAL VALIDITY, BIAS AND CONFOUNDING OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand

More information

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies

Observational Study Designs. Review. Today. Measures of disease occurrence. Cohort Studies Observational Study Designs Denise Boudreau, PhD Center for Health Studies Group Health Cooperative Today Review cohort studies Case-control studies Design Identifying cases and controls Measuring exposure

More information

Confounding and Interaction

Confounding and Interaction Confounding and Interaction Why did you do clinical research? To find a better diagnosis tool To determine risk factor of disease To identify prognosis factor To evaluate effectiveness of therapy To decide

More information

Challenges of Observational and Retrospective Studies

Challenges of Observational and Retrospective Studies Challenges of Observational and Retrospective Studies Kyoungmi Kim, Ph.D. March 8, 2017 This seminar is jointly supported by the following NIH-funded centers: Background There are several methods in which

More information

Confounding and Bias

Confounding and Bias 28 th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Barcelona, Spain August 22, 2012 Confounding and Bias Tobias Gerhard, PhD Assistant Professor, Ernest Mario School

More information

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example

Main objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example Main objective of Epidemiology Inference to a population Example: Treatment of hypertension: Research question (hypothesis): Is treatment A better than treatment B for patients with hypertension? Study

More information

University of Wollongong. Research Online. Australian Health Services Research Institute

University of Wollongong. Research Online. Australian Health Services Research Institute University of Wollongong Research Online Australian Health Services Research Institute Faculty of Business 2011 Measurement of error Janet E. Sansoni University of Wollongong, jans@uow.edu.au Publication

More information

INTERPRETATION OF STUDY FINDINGS: PART I. Julie E. Buring, ScD Harvard School of Public Health Boston, MA

INTERPRETATION OF STUDY FINDINGS: PART I. Julie E. Buring, ScD Harvard School of Public Health Boston, MA INTERPRETATION OF STUDY FINDINGS: PART I Julie E. Buring, ScD Harvard School of Public Health Boston, MA Drawing Conclusions TRUTH IN THE UNIVERSE Infer TRUTH IN THE STUDY Infer FINDINGS IN THE STUDY Designing

More information

Bias. A systematic error (caused by the investigator or the subjects) that causes an incorrect (overor under-) estimate of an association.

Bias. A systematic error (caused by the investigator or the subjects) that causes an incorrect (overor under-) estimate of an association. Bias A systematic error (caused by the investigator or the subjects) that causes an incorrect (overor under-) estimate of an association. Here, random error is small, but systematic errors have led to

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

Observational Medical Studies. HRP 261 1/13/ am

Observational Medical Studies. HRP 261 1/13/ am Observational Medical Studies HRP 261 1/13/03 10-11 11 am To Drink or Not to Drink? Volume 348:163-164 January 9, 2003 Ira J. Goldberg, M.D. A number of epidemiologic studies have found an association

More information

Confounding Bias: Stratification

Confounding Bias: Stratification OUTLINE: Confounding- cont. Generalizability Reproducibility Effect modification Confounding Bias: Stratification Example 1: Association between place of residence & Chronic bronchitis Residence Chronic

More information

Controlling Bias & Confounding

Controlling Bias & Confounding Controlling Bias & Confounding Chihaya Koriyama August 5 th, 2015 QUESTIONS FOR BIAS Key concepts Bias Should be minimized at the designing stage. Random errors We can do nothing at Is the nature the of

More information

Types of Biomedical Research

Types of Biomedical Research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency Family Medicine Section of

More information

12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C

12/26/2013. Types of Biomedical Research. Clinical Research. 7Steps to do research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH S T A T I S T I C Types of Biomedical Research INTRODUCTION & MEASUREMENT IN CLINICAL RESEARCH Sakda Arj Ong Vallipakorn, MD MSIT, MA (Information Science) Pediatrics, Pediatric Cardiology Emergency Medicine, Ped Emergency

More information

Epidemiologic Study Designs. (RCTs)

Epidemiologic Study Designs. (RCTs) Epidemiologic Study Designs Epidemiologic Study Designs Experimental (RCTs) Observational Analytical Descriptive Case-Control Cohort + cross-sectional & ecologic Epidemiologic Study Designs Descriptive

More information

Placebo-Controlled Statin Trials

Placebo-Controlled Statin Trials PREVENTION OF CHD WITH LIPID MANAGEMENT AND ASPIRIN: MATCHING TREATMENT TO RISK Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of

More information

Understanding Statistics for Research Staff!

Understanding Statistics for Research Staff! Statistics for Dummies? Understanding Statistics for Research Staff! Those of us who DO the research, but not the statistics. Rachel Enriquez, RN PhD Epidemiologist Why do we do Clinical Research? Epidemiology

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Clinical Research Design and Conduction

Clinical Research Design and Conduction Clinical Research Design and Conduction Study Design M Mohsen Ibrahim, MD Cardiac Department Cairo University Algorithm for classification of types of clinical research Grimes DA and Schulz KF. Lancet

More information

Causal Association : Cause To Effect. Dr. Akhilesh Bhargava MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur

Causal Association : Cause To Effect. Dr. Akhilesh Bhargava MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur Causal Association : Cause To Effect Dr. MD, DHA, PGDHRM Prof. Community Medicine & Director-SIHFW, Jaipur Measure of Association- Concepts If more disease occurs in a group that smokes compared to the

More information

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial

Experimental Design. Terminology. Chusak Okascharoen, MD, PhD September 19 th, Experimental study Clinical trial Randomized controlled trial Experimental Design Chusak Okascharoen, MD, PhD September 19 th, 2016 Terminology Experimental study Clinical trial Randomized controlled trial 1 PHASES OF CLINICAL TRIALS Phase I: First-time-in-man studies

More information

PTHP 7101 Research 1 Chapter Assignments

PTHP 7101 Research 1 Chapter Assignments PTHP 7101 Research 1 Chapter Assignments INSTRUCTIONS: Go over the questions/pointers pertaining to the chapters and turn in a hard copy of your answers at the beginning of class (on the day that it is

More information

Evidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013

Evidence-Based Medicine Journal Club. A Primer in Statistics, Study Design, and Epidemiology. August, 2013 Evidence-Based Medicine Journal Club A Primer in Statistics, Study Design, and Epidemiology August, 2013 Rationale for EBM Conscientious, explicit, and judicious use Beyond clinical experience and physiologic

More information

Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course

Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course Updates in Therapeutics 2015: The Pharmacotherapy Preparatory Review & Recertification Course Study Designs: Fundamentals and Interpretation Kevin M. Sowinski, Pharm.D., FCCP Purdue University, College

More information

Bias and confounding. Mads Kamper-Jørgensen, associate professor, Section of Social Medicine

Bias and confounding. Mads Kamper-Jørgensen, associate professor, Section of Social Medicine Bias and confounding Mads Kamper-Jørgensen, associate professor, maka@sund.ku.dk PhD-course in Epidemiology l 7 February 2017 l Slide number 1 The world according to an epidemiologist Exposure Outcome

More information

Online Supplementary Material

Online Supplementary Material Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control

More information

Study design. Chapter 64. Research Methodology S.B. MARTINS, A. ZIN, W. ZIN

Study design. Chapter 64. Research Methodology S.B. MARTINS, A. ZIN, W. ZIN Chapter 64 Study design S.B. MARTINS, A. ZIN, W. ZIN Research Methodology Scientific methodology comprises a set of rules and procedures to investigate the phenomena of interest. These rules and procedures

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Confounding. Confounding and effect modification. Example (after Rothman, 1998) Beer and Rectal Ca. Confounding (after Rothman, 1998)

Confounding. Confounding and effect modification. Example (after Rothman, 1998) Beer and Rectal Ca. Confounding (after Rothman, 1998) Confounding Confounding and effect modification Epidemiology 511 W. A. Kukull vember 23 2004 A function of the complex interrelationships between various exposures and disease. Occurs when the disease

More information

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total Chapter 10 Exercises 1. Intent-to-treat analysis: Example 1 In a randomized controlled trial to determine whether the nicotine patch reduces the risk of relapse among smokers who have committed to quit,

More information

Epidemiologic Methods and Counting Infections: The Basics of Surveillance

Epidemiologic Methods and Counting Infections: The Basics of Surveillance Epidemiologic Methods and Counting Infections: The Basics of Surveillance Ebbing Lautenbach, MD, MPH, MSCE University of Pennsylvania School of Medicine Nothing to disclose PENN Outline Definitions / Historical

More information

Clinical Evidence: Asking the Question and Understanding the Answer. Keeping Up to Date. Keeping Up to Date

Clinical Evidence: Asking the Question and Understanding the Answer. Keeping Up to Date. Keeping Up to Date Clinical Evidence: Asking the Question and Understanding the Answer Keeping Up to Date 5,000? per day 1,500 per day 95 per day Keeping Up to Date 5,000? per day 1,500 per day 95 per day 1 Bias Bias refers

More information

Understanding Confounding in Research Kantahyanee W. Murray and Anne Duggan. DOI: /pir

Understanding Confounding in Research Kantahyanee W. Murray and Anne Duggan. DOI: /pir Understanding Confounding in Research Kantahyanee W. Murray and Anne Duggan Pediatr. Rev. 2010;31;124-126 DOI: 10.1542/pir.31-3-124 The online version of this article, along with updated information and

More information

Measures of Association

Measures of Association Measures of Association Lakkana Thaikruea M.D., M.S., Ph.D. Community Medicine Department, Faculty of Medicine, Chiang Mai University, Thailand Introduction One of epidemiological studies goal is to determine

More information

Advanced IPD meta-analysis methods for observational studies

Advanced IPD meta-analysis methods for observational studies Advanced IPD meta-analysis methods for observational studies Simon Thompson University of Cambridge, UK Part 4 IBC Victoria, July 2016 1 Outline of talk Usual measures of association (e.g. hazard ratios)

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002

Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 DETAILED COURSE OUTLINE Epidemiologic Methods I & II Epidem 201AB Winter & Spring 2002 Hal Morgenstern, Ph.D. Department of Epidemiology UCLA School of Public Health Page 1 I. THE NATURE OF EPIDEMIOLOGIC

More information

Epidemiological study design. Paul Pharoah Department of Public Health and Primary Care

Epidemiological study design. Paul Pharoah Department of Public Health and Primary Care Epidemiological study design Paul Pharoah Department of Public Health and Primary Care Molecules What/why? Organelles Cells Tissues Organs Clinical medicine Individuals Public health medicine Populations

More information

Improved control for confounding using propensity scores and instrumental variables?

Improved control for confounding using propensity scores and instrumental variables? Improved control for confounding using propensity scores and instrumental variables? Dr. Olaf H.Klungel Dept. of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences

More information

INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD.

INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD. INTRODUCTION TO EPIDEMIOLOGICAL STUDY DESIGNS PHUNLERD PIYARAJ, MD., MHS., PHD. 1 OBJECTIVES By the end of this section, you will be able to: Provide a definition of epidemiology Describe the major types

More information

Bias. Zuber D. Mulla

Bias. Zuber D. Mulla Bias Zuber D. Mulla Explanations when you Observe or Don t Observe an Association Truth Chance Bias Confounding From Epidemiology in Medicine (Hennekens & Buring) Bias When you detect an association or

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

Basic Biostatistics. Dr. Kiran Chaudhary Dr. Mina Chandra

Basic Biostatistics. Dr. Kiran Chaudhary Dr. Mina Chandra Basic Biostatistics Dr. Kiran Chaudhary Dr. Mina Chandra Overview 1.Importance of Biostatistics 2.Biological Variations, Uncertainties and Sources of uncertainties 3.Terms- Population/Sample, Validity/

More information

Welcome to this third module in a three-part series focused on epidemiologic measures of association and impact.

Welcome to this third module in a three-part series focused on epidemiologic measures of association and impact. Welcome to this third module in a three-part series focused on epidemiologic measures of association and impact. 1 This three-part series focuses on the estimation of the association between exposures

More information

Critical Appraisal Series

Critical Appraisal Series Definition for therapeutic study Terms Definitions Study design section Observational descriptive studies Observational analytical studies Experimental studies Pragmatic trial Cluster trial Researcher

More information

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis

Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard

More information

3. Factors such as race, age, sex, and a person s physiological state are all considered determinants of disease. a. True

3. Factors such as race, age, sex, and a person s physiological state are all considered determinants of disease. a. True / False 1. Epidemiology is the basic science of public health. LEARNING OBJECTIVES: CNIA.BOYL.17.2.1 - Define epidemiology. 2. Within the field of epidemiology, the term distribution refers to the relationship

More information

EPI 200C Final, June 4 th, 2009 This exam includes 24 questions.

EPI 200C Final, June 4 th, 2009 This exam includes 24 questions. Greenland/Arah, Epi 200C Sp 2000 1 of 6 EPI 200C Final, June 4 th, 2009 This exam includes 24 questions. INSTRUCTIONS: Write all answers on the answer sheets supplied; PRINT YOUR NAME and STUDENT ID NUMBER

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Quantitative Research Methods and Tools

Quantitative Research Methods and Tools Quantitative Research Methods and Tools Fraser Health Authority, 2011 The Fraser Health Authority ( FH ) authorizes the use, reproduction and/or modification of this publication for purposes other than

More information

Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto

Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death. Debra Moy Faculty of Pharmacy University of Toronto Critical Appraisal of a Meta-Analysis: Rosiglitazone and CV Death Debra Moy Faculty of Pharmacy University of Toronto Goal To provide practitioners with a systematic approach to evaluating a meta analysis

More information

Using negative control outcomes to identify biased study design: A self-controlled case series example. James Weaver 1,2.

Using negative control outcomes to identify biased study design: A self-controlled case series example. James Weaver 1,2. Using negative control outcomes to identify biased study design: A self-controlled case series example James Weaver 1,2 1Janssen Research & Development, LLC, Raritan, NJ, USA 2 Observational Health Data

More information

Incorporating Clinical Information into the Label

Incorporating Clinical Information into the Label ECC Population Health Group LLC expertise-driven consulting in global maternal-child health & pharmacoepidemiology Incorporating Clinical Information into the Label Labels without Categories: A Workshop

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials MANAGEMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR RISK IN WOMEN: Balancing Benefits and Harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

RANDOMIZED CLINICAL TRIALS. Study Designs. Randomized Clinical Trials (RCT) ASSIGN EXPOSURE Follow up Check for OUTCOME. Experimental studies

RANDOMIZED CLINICAL TRIALS. Study Designs. Randomized Clinical Trials (RCT) ASSIGN EXPOSURE Follow up Check for OUTCOME. Experimental studies RANDOMIZED CLINICAL TRIALS Study Designs Observational studies Analytic studies Descriptive studies Randomized Controlled trials Case control Cohort Cross sectional Randomized Clinical Trials (RCT) Assign

More information

Research Methodology Workshop. Study Type

Research Methodology Workshop. Study Type Research Methodology Workshop Study Type What type of question? Frequency: how common is it? Aetiology: What caused this? Intervention: Does this intervention work? Diagnosis or test evaluation: How accurate

More information

Welcome to this series focused on sources of bias in epidemiologic studies. In this first module, I will provide a general overview of bias.

Welcome to this series focused on sources of bias in epidemiologic studies. In this first module, I will provide a general overview of bias. Welcome to this series focused on sources of bias in epidemiologic studies. In this first module, I will provide a general overview of bias. In the second module, we will focus on selection bias and in

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS: WHERE DO WE STAND WITH THE NEW PRACTICE GUIDELINES? Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant financial relationships

More information

Epidemiology: Overview of Key Concepts and Study Design. Polly Marchbanks

Epidemiology: Overview of Key Concepts and Study Design. Polly Marchbanks Epidemiology: Overview of Key Concepts and Study Design Polly Marchbanks Lecture Outline (1) Key epidemiologic concepts - Definition - What epi is not - What epi is - Process of epi research Lecture Outline

More information

Glossary of Practical Epidemiology Concepts

Glossary of Practical Epidemiology Concepts Glossary of Practical Epidemiology Concepts - 2009 Adapted from the McMaster EBCP Workshop 2003, McMaster University, Hamilton, Ont. Note that open access to the much of the materials used in the Epi-546

More information

Is There An Association?

Is There An Association? Is There An Association? Exposure (Risk Factor) Outcome Exposures Risk factors Preventive measures Management strategy Independent variables Outcomes Dependent variable Disease occurrence Lack of exercise

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press)

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press) Education level and diabetes risk: The EPIC-InterAct study 50 authors from European countries Int J Epidemiol 2012 (in press) Background Type 2 diabetes mellitus (T2DM) is one of the most common chronic

More information

Data that can be classified as belonging to a distinct number of categories >>result in categorical responses. And this includes:

Data that can be classified as belonging to a distinct number of categories >>result in categorical responses. And this includes: This sheets starts from slide #83 to the end ofslide #4. If u read this sheet you don`t have to return back to the slides at all, they are included here. Categorical Data (Qualitative data): Data that

More information

Addressing error in laboratory biomarker studies

Addressing error in laboratory biomarker studies Addressing error in laboratory biomarker studies Elizabeth Selvin, PhD, MPH Associate Professor of Epidemiology and Medicine Co-Director, Biomarkers and Diagnostic Testing Translational Research Community

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy?

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy? Macrovascular Residual Risk What risk remains after LDL-C management and intensive therapy? Defining Residual Vascular Risk The risk of macrovascular events and microvascular complications which persists

More information

Study Designs. Randomized Clinical Trials (RCT) RCT: Example 1. RCT: Two by Two Table. Outcome. Exposure. Yes a b No c d

Study Designs. Randomized Clinical Trials (RCT) RCT: Example 1. RCT: Two by Two Table. Outcome. Exposure. Yes a b No c d Study Designs Randomized Clinical Trials (RCT) Assign Exposure Randomly Experimental studies Analytic studies Observational studies Descriptive studies POPULATION Population People without the outcome

More information

General Biostatistics Concepts

General Biostatistics Concepts General Biostatistics Concepts Dongmei Li Department of Public Health Sciences Office of Public Health Studies University of Hawai i at Mānoa Outline 1. What is Biostatistics? 2. Types of Measurements

More information

Department of OUTCOMES RESEARCH

Department of OUTCOMES RESEARCH Department of OUTCOMES RESEARCH Clinical Research Design Sources of Error Types of Clinical Research Randomized Trials! Daniel I. Sessler, M.D. Professor and Chair Department of OUTCOMES RESEARCH The Cleveland

More information

Confounding, Effect modification, and Stratification

Confounding, Effect modification, and Stratification Confounding, Effect modification, and Stratification Tunisia, 30th October 2014 Acknowledgment: Kostas Danis Takis Panagiotopoulos National Schoool of Public Health, Athens, Greece takis.panagiotopoulos@gmail.com

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Clinical problems and choice of study designs

Clinical problems and choice of study designs Evidence Based Dentistry Clinical problems and choice of study designs Asbjørn Jokstad University of Oslo, Norway Nov 21 2001 1 Manipulation with intervention Yes Experimental study No Non-experimental

More information

EVect of measurement error on epidemiological studies of environmental and occupational

EVect of measurement error on epidemiological studies of environmental and occupational Occup Environ Med 1998;55:651 656 651 METHODOLOGY Series editors: T C Aw, A Cockcroft, R McNamee Correspondence to: Dr Ben G Armstrong, Environmental Epidemiology Unit, London School of Hygiene and Tropical

More information

Preventive Cardiology Scientific evidence

Preventive Cardiology Scientific evidence Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention

More information

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL Daniel E. Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Introduction to Clinical Research July 15, 2014 STUDY DESIGN Provides

More information

Fitting the Method to the Question

Fitting the Method to the Question Quantitative Research Design: Fitting the Method to the Question Deborah Eldredge, PhD, RN Director, Nursing Quality, Research & Magnet Oregon Health & Science University Healthcare Margo A. Halm, RN,

More information

Cardiovascular Outcome

Cardiovascular Outcome Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Cardiovascular Outcome D R. J E F F R E Y G O L D B E R G E R U

More information

The Evidence for Populationwide Reduction in Sodium Intake: Why All the Fuss?

The Evidence for Populationwide Reduction in Sodium Intake: Why All the Fuss? The Evidence for Populationwide Reduction in Sodium Intake: Why All the Fuss? CIA-Harvard Menus of Change National Leadership Summit June 10, 2014 Cambridge, MA General Session IV Lawrence J Appel, MD,

More information

Protocol Development: The Guiding Light of Any Clinical Study

Protocol Development: The Guiding Light of Any Clinical Study Protocol Development: The Guiding Light of Any Clinical Study Susan G. Fisher, Ph.D. Chair, Department of Clinical Sciences 1 Introduction Importance/ relevance/ gaps in knowledge Specific purpose of the

More information

Nicotine replacement therapy to improve quit rates

Nicotine replacement therapy to improve quit rates Nicotine replacement therapy to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England to undertake a

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

EPIDEMIOLOGY-BIOSTATISTICS EXAM Midterm 2004 PRINT YOUR LEGAL NAME:

EPIDEMIOLOGY-BIOSTATISTICS EXAM Midterm 2004 PRINT YOUR LEGAL NAME: EPIDEMIOLOGY-BIOSTATISTICS EXAM Midterm 2004 PRINT YOUR LEGAL NAME: Instructions: This exam is 20% of your course grade. The maximum number of points for the course is 1,000; hence, this exam is worth

More information

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS Lester Jao Lacorte, MD, CCRP Medical Officer Office of Science Center for Tobacco Products U.S. Food and Drug Administration DISCLAIMER 1 The information

More information

Pharmacy practice research is

Pharmacy practice research is Research fundamentals Bias: Considerations for research practice Tobias Gerhard Pharmacy practice research is multifaceted and includes a variety of settings, study questions, and study designs. This report

More information

Penelitian IKM/Epidemiologi. Contact: Blog: suyatno.blog.undip.ac.id Hp/Telp: /

Penelitian IKM/Epidemiologi. Contact:   Blog: suyatno.blog.undip.ac.id Hp/Telp: / Penelitian IKM/Epidemiologi Oleh : Suyatno, Ir. MKes Contact: E-mail: suyatnofkmundip@gmail.com Blog: suyatno.blog.undip.ac.id Hp/Telp: 08122815730 / 024-70251915 Epidemiologic Study Designs I. Experimental

More information

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL?

CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? CAN EFFECTIVENESS BE MEASURED OUTSIDE A CLINICAL TRIAL? Mette Nørgaard, Professor, MD, PhD Department of Clinical Epidemiology Aarhus Universitety Hospital Aarhus, Denmark Danish Medical Birth Registry

More information

Proton Pump Inhibitors increase Cardiovascular risk in patient taking Clopidogrel

Proton Pump Inhibitors increase Cardiovascular risk in patient taking Clopidogrel Proton Pump Inhibitors increase Cardiovascular risk in patient taking Clopidogrel Dr.A.K.M. Aminul Hoque Assoc. Prof. of Medicine. Dhaka Medical College. Clopidogrel Metabolism Clopidogrel is an inactive

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Epidemiologic study designs

Epidemiologic study designs Epidemiologic study designs and critical appraisal of scientific papers Rolf H.H. Groenwold, MD, PhD Bio sketch MD, PhD in epidemiology Associate professor of Epidemiology at UMC Utrecht Research focus

More information

Epidemiology & Evidence Based Medicine. Patrick Linden & Matthew McCall

Epidemiology & Evidence Based Medicine. Patrick Linden & Matthew McCall Epidemiology & Evidence Based Medicine Patrick Linden & Matthew McCall Areas Covered in this Talk Bradford Hill Criteria Bias and confounding Study designs, advantages and disadvantages Basic definitions

More information

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering

Meta-Analysis. Zifei Liu. Biological and Agricultural Engineering Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis

More information

Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case-control study

Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case-control study Abacavir is associated with increased risk of cardiovascular disease in HIV-infected patients: A UK clinic case-control study Collins Iwuji, Duncan Churchill, Yvonne Gilleece, Martin Fisher Brighton and

More information

ADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL

ADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL ADENIYI MOFOLUWAKE MPH 510 - APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL 4 2013 Question 1: What makes the first study a case-control study? The first case study is a case-control study because

More information

The Need for Balance in Evaluating the Evidence on Na and CVD

The Need for Balance in Evaluating the Evidence on Na and CVD The Need for Balance in Evaluating the Evidence on Na and CVD Salim Yusuf Professor of Medicine, McMaster University Executive Director, Population Health Research Institute Vice-President Research, Hamilton

More information

Purpose. Study Designs. Objectives. Observational Studies. Analytic Studies

Purpose. Study Designs. Objectives. Observational Studies. Analytic Studies Purpose Study Designs H.S. Teitelbaum, DO, PhD, MPH, FAOCOPM AOCOPM Annual Meeting Introduce notions of study design Clarify common terminology used with description and interpretation of information collected

More information

Biostatistics and Epidemiology Step 1 Sample Questions Set 1

Biostatistics and Epidemiology Step 1 Sample Questions Set 1 Biostatistics and Epidemiology Step 1 Sample Questions Set 1 1. A study wishes to assess birth characteristics in a population. Which of the following variables describes the appropriate measurement scale

More information